PLTR

Palantir Technologies Inc.

$194.15

+4.36% 2026-10-19

Information TechnologyS&P 500

1M 3M 6M 1Y 2Y

PLTRSPY

-7.1%

+9.3%

+44.0%

+33.1%

YTD

+9.2%

+9.0%

Grades vs sector

Momentum

33rd pct in sector

C-

12-1 return: -6.7%
Percentile within its GICS sector across the S&P 1500.

Growth

96th pct in sector

A+

Revenue growth (YoY): +92.8%
Percentile within its GICS sector across the S&P 1500.

Value

3rd pct in sector

Forward E/P: 1.3% · EBITDA/EV: 0.6%
Percentile within its GICS sector across the S&P 1500.

Profitability

90th pct in sector

Profit margin: +49.0% · Return on equity: +38.1%
Percentile within its GICS sector across the S&P 1500.

Revisions

no data

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Held by 1 of 3 live models: Quality Growth.

Quality Growth

6.7% of the book · rank 14 of 360

Held Momentum Top 15

rank 316 of 499 · 12-1 momentum % 2.2

Momentum Blend

not in the current book

Why it's in Quality Growth #14 of 360

Qualified on ROIC 27%, revenue +79% (TTM), growth accelerating +22.4 pts, latest quarter 2026-06-30. Ranked 14th of 360 at the 2026-09-30 rebalance.

What would knock it out: Drops out if it falls outside the top 15 at the next rebalance (Oct 30). In the latest preview (2026-10-16) it ranks 14th.

Key stats

Market cap$466.6B

P/E (trailing)167.4

P/E (forward)82.6

52-week range106.37 – 212.94

Revenue growth (YoY, latest qtr)+92.8%

Dividend yield0.00%

Analyst consensusBuy (26)

Mean price target$206.43 (+6%)

Valuation & fundamentals

Bottom line

Leans expensive

Model read-out from the numbers below, not advice. Score -2 (DCF counts double).

▼DCF (base case)below the price by 67%

▼Forward P/E vs sector82.6x vs median 16.9x

▲Piotroski F-score8/9

▲Altman Z158.1 (safe)

▲Net debt / EBITDA-3.5x

•Analyst target+6% (26 analysts)

Discounted cash flow

Bear

$32

-83%

growth 18% · disc. 13.3% · term. 2.0%

Base

$63

-67%

growth 30% · disc. 12.3% · term. 2.5%

Bull

$107

-45%

growth 38% · disc. 11.3% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 40% a year for 10 years.

Implied

+40%/yr

FCF, last 3 yrs

+125%/yr

FCF, last 5 yrs

n/a

Revenue, last 3 yrs

+33%/yr

Revenue, last 5 yrs

+33%/yr

Same inputs as the DCF above: trailing free cash flow 3.4B, 12.3% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.60 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Information Technology

P/E (trailing)

sector median 35.9× · 95th pct

167.4×
pricier

Forward P/E

sector median 16.9× · 98th pct

82.6×
pricier

EV / EBITDA

sector median 20.8× · 97th pct

171.7×
pricier

Price / sales

sector median 4.6× · 99th pct

75.8×
pricier

Price / book

sector median 5.1× · 97th pct

47.7×
pricier

FCF yield

sector median 3.5% · 14th pct

0.7%
pricier

Forward EPS $2.35 vs trailing $1.16 (+103% expected growth). Forward P/E uses analysts' next-12-month estimate.

Backlog (remaining performance obligations)

RPO

$4.9B

as of 2026-06-30

vs a year ago

+104%

YoY

× TTM revenue

0.80×

coverage

24-09

24-12

25-03

25-06

25-09

25-12

26-03

26-06

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin

84.8%

Operating margin

42.8%

FCF margin

54.6%

Net margin

49.0%

Return on equity

30.9%

Return on invested capital

712.0%

Net debt / EBITDA

-3.5×

Current ratio

7.2×

Interest cover

759.3×

Cash conversion (OCF/NI)

1.1×

Piotroski F-score 8/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved

Altman Z-score 158.1 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$206

+6%

Analysts

Buy

Range

$80–$265

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$4.5B	$1.6B	$2.1B
2024	$2.9B	$462.2M	$1.1B
2023	$2.2B	$209.8M	$697.1M
2022	$1.9B	$-373.7M	$183.7M
2021	$1.5B	$-520.4M	$321.2M
2020	$1.1B	$-1.2B	$-308.8M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +32.9%.

Earnings

Next report: 2026-11-02 · during market · EPS est 0.41

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-03	0.35	0.41	+18.5%
2026-05-04	0.28	0.33	+18.1%
2026-02-02	0.23	0.25	+8.6%
2025-11-03	0.17	0.21	+25.5%
2025-08-04	0.14	0.16	+15.6%
2025-05-05	0.13	0.13	+1.1%
2025-02-03	0.11	0.14	+23.7%
2024-11-04	0.09	0.10	+10.1%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$1.9B	+92.8%
2026-03-31	$1.6B	–
2025-12-31	$1.4B	–
2025-09-30	$1.2B	–
2025-06-30	$1.0B	–

Analyst actions

Mizuho

2026-10-15 · main

Outperform → Outperform
PT $245

Barclays

2026-10-09 · init

→ Overweight
PT $265

Goldman Sachs

2026-10-08 · up

Neutral → Buy
PT $230

Rosenblatt

2026-09-23 · main

Buy → Buy
PT $225

UBS

2026-09-15 · main

Buy → Buy
PT $250

DA Davidson

2026-09-11 · main

Buy → Buy
PT $250

Insider trades

Woersching Eric H.

Director · 2026-10-09

SELL
$205.0K

Stat Lauren Elaina Friedman

Director · 2026-10-08

SELL
$1.0M

Taylor Ryan D.

See Remarks · 2026-10-08

SELL
$3.6M

Stat Lauren Elaina Friedman

Director · 2026-10-01

SELL
$254.0K

Moore Alexander D.

Director · 2026-09-15

SELL
$222.7K

Moore Alexander D.

Director · 2026-09-15

SELL
$667.4K

Moore Alexander D.

Director · 2026-09-15

SELL
$687.2K

Moore Alexander D.

Director · 2026-09-15

SELL
$401.3K

Moore Alexander D.

Director · 2026-09-15

SELL
$371.0K

Moore Alexander D.

Director · 2026-09-15

SELL
$322.8K

Moore Alexander D.

Director · 2026-09-15

SELL
$89.8K

Stat Lauren Elaina Friedman

Director · 2026-09-01

SELL
$244.9K

News

Palantir, Datadog and chip stocks bounce back as Amazon lifts Wall Street

Yahoo Finance · 7h ago

Palantir Wins Knox Federal Partnership, Gains 4%

TIKR · 7h ago

Cathie Wood Dumps $12 Million of Palantir Stock in Two Days

GuruFocus.com · 8h ago

Palantir Stock Is Near a Record High. Should Investors Sell?

Nasdaq · 8h ago

Four Reasons Wall Street Has Eyes On This S&P 500 Stock

Investor's Business Daily · 10h ago

Why Palantir Technologies Stock Rallied Today

Nasdaq · 11h ago

Palantir Rises 5% on Knox Partnership for Federal Cloud Software; Leidos Edges Higher, Booz Allen Hamilton Slips

24/7 Wall St. · 12h ago

Why is Palantir Technologies stock rallying today?

Investing.com · 13h ago

Palantir Partners With Knox System For Customer Support With Missions In FedRAMP

Nasdaq · 14h ago

Sector Update: Tech Stocks Rise Premarket Monday

MT Newswires · 14h ago

Stats refreshed 2026-10-19 17:47:14 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic StrategiesSystematic equity research and model portfolios.
Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.

What is Coteau?Disclaimer Terms Privacy Data status